202
Views
34
CrossRef citations to date
0
Altmetric
Original Research

Autoimmunity in a cohort of 471 patients with primary antibody deficiencies

, , , , , , , , , , , , & show all
Pages 1099-1106 | Received 18 Jun 2017, Accepted 21 Sep 2017, Published online: 11 Oct 2017

References

  • Abolhassani H, Parvaneh N, Rezaei N, et al. Genetic defects in B-cell development and their clinical consequences. J Invest Allergol Clin Immunol. 2014;24:6–22; quiz 2 p following.
  • Durandy A, Kracker S, Fischer A. Primary antibody deficiencies. Nat Rev Immunol. 2013;13:519–533.
  • Gathmann B, Binder N, Ehl S, et al. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2012;167:479–491.
  • Kindle G, Gathmann B, Grimbacher B. The use of databases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol. 2014;14:501–508.
  • Edgar JD, Buckland M, Guzman D, et al. The United Kingdom Primary Immune Deficiency (UKPID) registry: report of the first 4 years’ activity 2008-2012. Clin Exp Immunol. 2014;175:68–78.
  • Milá Llambí J, Etxagibel Galdos A, Matamoros Florí N. [The Spanish registry of primary immunodeficiencies (REDIP)]. Allergol Immunopathol. 2001;29:122–125.
  • Plebani A, Soresina A, Notarangelo LD, et al. The Italian network of primary immunodeficiencies. Iran J Allergy Asthma Immunol. 2004;3:165–168.
  • Yazdani R, Seify R, Ganjalikhani-Hakemi M, et al. Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets. Allergol Immunopathol. 2017;45:183–192.
  • Tak Manesh A, Azizi G, Heydari A, et al. Epidemiology and pathophysiology of malignancy in common variable immunodeficiency? Allergol Immunopathol. 2001;29(3):122–125.
  • Yazdani R, Azizi G, Abolhassani H, et al. Selective IgA deficiency: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management. Scand J Immunol. 2017;85:3–12.
  • Yazdani R, Heydari A, Azizi G, et al. Asthma and allergic diseases in a selected group of patients with common variable immunodeficiency. J Invest Allergol Clin Immunol. 2016;26:209–211.
  • Azizi G, Abolhassani H, Mahdaviani SA, et al. Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: a longitudinal study. Pediatr Allergy Immunol. 2017;28:478–484.
  • Sarmiento E, Mora R, Rodriguez-Mahou M, et al. [Autoimmune disease in primary antibody deficiencies]. Allergol Immunopathol. 2005;33:69–73.
  • Azizi G, Abolhassani H, Asgardoon MH, et al. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Rev Clin Immunol. 2017;13(2):101–115.
  • Pessach IM. The relationship of X-linked primary immune deficiencies and autoimmunity. Curr Allergy Asthma Rep. 2010;10:311–319.
  • Yazdani R, Latif A, Tabassomi F, et al. Clinical phenotype classification for selective immunoglobulin A deficiency. Expert Rev Clin Immunol. 2015;11:1245–1254.
  • Cabral-Marques O, Klaver S, Schimke LF, et al. First report of the hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes. J Clin Immunol. 2014;34:146–156.
  • Rahiminejad MS, Mirmohammad Sadeghi M, Mohammadinejad P, et al. Evaluation of humoral immune function in patients with chronic idiopathic thrombocytopenic purpura. Iran J Allergy Asthma Immunol. 2013;12:50–56.
  • Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190–197.
  • European Societies for Immunodeficiencies. 2017. Clinical diagnostic criteria for PID. Available from: https://esid.org/Working-Parties/Clinical/Resources/Diagnostic-criteria-for-PID2
  • Arandi N, Mirshafiey A, Abolhassani H, et al. Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency. Scand J Immunol. 2013;77:405–412.
  • Arandi N, Mirshafiey A, Jeddi-Tehrani M, et al. Evaluation of CD4+CD25+FOXP3+ regulatory T cells function in patients with common variable immunodeficiency. Cell Immunol. 2013;281:129–133.
  • Yazdani R, Ganjalikhani-Hakemi M, Esmaeili M, et al. Impaired Akt phosphorylation in B-cells of patients with common variable immunodeficiency. Clin Immunol. 2017;175:124–132.
  • Shoenfeld Y, Cervera R, Gershwin ME, editors. Diagnostic criteria in autoimmune diseases. Humana Press, Springer Science Business Media, LLC; 2008. DOI: 10.1007/978-1-60327-285-8.
  • Azizi G, Ghanavatinejad A, Abolhassani H, et al. Autoimmunity in primary T-cell immunodeficiencies. Expert Rev Clin Immunol. 2016;12:989–1006.
  • Marefat H, Abolhassani H, Ghareje Daghi M, et al. Early onset steroid induced posterior subcapsular cataract in a patient with common variable immunodeficiency: case reports and review of literature. Eur Ann Allergy Clin Immunol. 2016;48:197–201.
  • Azizi G, Pouyani MR, Abolhassani H, et al. Cellular and molecular mechanisms of immune dysregulation and autoimmunity. Cell Immunol. 2016;310:14–26.
  • Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33:197–207.
  • Azizi G, Ziaee V, Tavakol M, et al. Approach to the management of autoimmunity in primary immunodeficiency. Scand J Immunol. 2017;85:13–29.
  • Azizi G, Abolhassani H, Kiaee F, et al. Autoimmunity and its association with regulatory T cells and B cell subsets in patients with common variable immunodeficiency. Allergol Immunopathol. 2017. pii: S0301-0546(17)30075-7. [Epub ahead of print]
  • Ramyar A, Aghamohammadi A, Moazzami K, et al. Presence of idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency. Iran J Allergy Asthma Immunol. 2008;7:169–175.
  • Heeney MM, Zimmerman SA, Ware RE. Childhood autoimmune cytopenia secondary to unsuspected common variable immunodeficiency. J Pediatr. 2003;143:662–665.
  • Warnatz K, Voll RE. Pathogenesis of autoimmunity in common variable immunodeficiency. Front Immunol. 2012;3:210.
  • Azizi G, Abolhassani H, Rezaei N, et al. The use of immunoglobulin therapy in primary immunodeficiency diseases. Endocr Metab Immune Disord Drug Targets. 2016;16:80–88.
  • Todoric K, Koontz JB, Mattox D, et al. Autoimmunity in immunodeficiency. Curr Allergy Asthma Rep. 2013;13:361–370.
  • Azizi G, Ahmadi M, Abolhassani H, et al. Autoimmunity in primary antibody deficiencies. Int Arch Allergy Immunol. 2016;171:180–193.
  • Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131:47–54.
  • Patiroglu T, Gungor HE, Unal E. Autoimmune diseases detected in children with primary immunodeficiency diseases: results from a reference centre at middle anatolia. Acta Microbiol Immunol Hung. 2012;59:343–353.
  • Jacob CM, Pastorino AC, Fahl K, et al. Autoimmunity in IgA deficiency: revisiting the role of IgA as a silent housekeeper. J Clin Immunol. 2008;28 Suppl 1:S56–61.
  • Abolhassani H, Gharib B, Shahinpour S, et al. Autoimmunity in patients with selective IgA deficiency. J Invest Allergol Clin Immunol. 2015;25:112–119.
  • Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, et al. Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol. 2014;34:627–632.
  • Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol. 2008;173:600–609.
  • Abolhassani H, Amirkashani D, Parvaneh N, et al. Autoimmune phenotype in patients with common variable immunodeficiency. J Invest Allergol Clin Immunol. 2013;23:323–329.
  • Ortona E, Pierdominici M, Maselli A, et al. Sex-based differences in autoimmune diseases. Annali dell’Istituto Superiore Di Sanita. 2016;52:205–212.
  • Saeidi S, Jaseb K, Asnafi AA, et al. Immune thrombocytopenic purpura in children and adults: a comparative retrospective study in IRAN. Int J Hematol-Oncol Stem Cell Res. 2014;8:30–36.
  • Cojocaru M, Cojocaru IM, Silosi I. Multiple autoimmune syndrome. Maedica. 2010;5:132–134.
  • Lo B, Zhang K, Lu W, et al. Autoimmune disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science. 2015;349:436–440.
  • Alangari A, Alsultan A, Adly N, et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J Allergy Clin Immunol. 2012;130:481–8.e2.
  • Azizi G, Hafezi N, Mohammadi H, et al. Abnormality of regulatory T cells in common variable immunodeficiency. Cell Immunol. 2017;315:11–17.
  • Soheili H, Abolhassani H, Arandi N, et al. Evaluation of natural regulatory T cells in subjects with selective IgA deficiency: from senior idea to novel opportunities. Int Arch Allergy Immunol. 2013;160:208–214.
  • Genre J, Errante PR, Kokron CM, et al. Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with common variable immunodeficiency: a link to autoimmunity? Clin Immunol. 2009;132:215–221.
  • Melo KM, Carvalho KI, Bruno FR, et al. A decreased frequency of regulatory T cells in patients with common variable immunodeficiency. PloS One. 2009;4:e6269.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.